Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents

J Med Chem. 2006 Jun 1;49(11):3064-7. doi: 10.1021/jm060405f.

Abstract

The synthesis of a new class of peptidomimetics 1a-j, based on a 1,4-benzodiazepine scaffold and on a C-terminal aspartyl aldehyde building block, is described. Compounds 1a-j provided significant inhibitory activity against falcipains 2A and 2B (FP-2A and FP-2B), two cysteine proteases from Plasmodium falciparum.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antimalarials / chemical synthesis*
  • Antimalarials / chemistry
  • Aspartic Acid / analogs & derivatives*
  • Aspartic Acid / chemistry
  • Benzodiazepines / chemical synthesis*
  • Benzodiazepines / chemistry
  • Cysteine Endopeptidases / chemistry
  • Cysteine Proteinase Inhibitors / chemical synthesis*
  • Cysteine Proteinase Inhibitors / chemistry
  • Molecular Mimicry
  • Peptides / chemistry*
  • Plasmodium falciparum / enzymology
  • Structure-Activity Relationship

Substances

  • Antimalarials
  • Cysteine Proteinase Inhibitors
  • Peptides
  • Benzodiazepines
  • Aspartic Acid
  • aspartic semialdehyde
  • Cysteine Endopeptidases
  • falcipain 2